Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis. [electronic resource] by
- Zhuang, Yanli
- Calderon, Cesar
- Marciniak, Stanley J
- Bouman-Thio, Esther
- Szapary, Philippe
- Yang, Tong-Yuan
- Schantz, Allen
- Davis, Hugh M
- Zhou, Honghui
- Xu, Zhenhua
Producer: 20170223
In:
European journal of clinical pharmacology vol. 72
Availability: No items available.
|
|
7.
|
|
|
8.
|
|
|
9.
|
Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis. [electronic resource] by
- Sofen, Howard
- Smith, Stacy
- Matheson, Robert T
- Leonardi, Craig L
- Calderon, Cesar
- Brodmerkel, Carrie
- Li, Katherine
- Campbell, Kim
- Marciniak, Stanley J
- Wasfi, Yasmine
- Wang, Yuhua
- Szapary, Philippe
- Krueger, James G
Producer: 20140616
In:
The Journal of allergy and clinical immunology vol. 133
Availability: No items available.
|
|
10.
|
Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol. [electronic resource] by
- Kuhn, Annegret
- Wozniacka, Anna
- Szepietowski, Jacek C
- Gläser, Regine
- Lehmann, Percy
- Haust, Merle
- Sysa-Jedrzejowska, Anna
- Reich, Adam
- Oke, Vilija
- Hügel, Rainer
- Calderon, Cesar
- de Vries, Dick E
- Nyberg, Filippa
Producer: 20111003
In:
The Journal of investigative dermatology vol. 131
Availability: No items available.
|
|
11.
|
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis. [electronic resource] by
- Deodhar, Atul
- Gensler, Lianne S
- Sieper, Joachim
- Clark, Michael
- Calderon, Cesar
- Wang, Yuhua
- Zhou, Yiying
- Leu, Jocelyn H
- Campbell, Kim
- Sweet, Kristen
- Harrison, Diane D
- Hsia, Elizabeth C
- van der Heijde, Désirée
Producer: 20191104
In:
Arthritis & rheumatology (Hoboken, N.J.) vol. 71
Availability: No items available.
|